Circulating IL-2 and IL-10 in chronic active hepatitis C with respect to the response to IFN treatment

Infection

Volumn 28, Issue 5, 2000, Pages 309-313

  Bozkaya, H ^a   Bozdayi, A M ^a   Aslan, N ^a   Turkay C ^a   Sarioglu, M ^a   Cetinkaya H ^a   Akdogan, M ^b   Cinar, K ^a   Erden, E ^a   Kose K ^a   Senturk H ^c   Akkiz, H ^d   Karayalcin, S ^a   Yurdaydin, C ^a   Uzunalimoglu, O ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Hepatitis C virus; IL 10; IL 2; Interferon treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MALE; VIRUS DETECTION; VIRUS TITRATION;

ADULT; ALANINE TRANSAMINASE; COMPARATIVE STUDY; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMAN; INTERFERON ALFA-2B; INTERLEUKIN-10; INTERLEUKIN-2; MALE; MIDDLE AGE; RNA, VIRAL; TIME FACTORS;

EID: 0033770732     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s150100070025     Document Type: Article

References (30)

1. Immune responses in hepatitis C virus infection
2. The role of immune responses in the pathogenesis of hepatitis C
3. A primer on cytokines: Sources, receptors, effects, and inducers
4. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
5. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections
6. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release
7. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: Effects of interferon-alpha (IFN-alpha) treatment
8. Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells
9. Chronic hepatitis C: T-helper1/T-helper2 imbalance could cause virus persistence in peripheral blood
10. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes
11. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines
12. Semiqua ntitative analysis of intrahepatic cytokine mRNAs in chronic hepatitis C
13. Production of cytokines in patients infected by hepatitis C virus
14. Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection
15. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa
16. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease
17. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection
18. Decrease of interferon gamma serum levels in patients with chronic hepatitis C
19. Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-gamma is elevated in patients with hepatitis C infection
20. High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C
21. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
22. Single step method of RNA isolation by acid-guanidium thiocyanate-phenol-chloroform extraction
23. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants
24. Prevalence and genotyping of hepatitis C virus RNA in Turkish patients with chronic non-A, non-B liver disease
25. The distribution of hepatitis C virus genotypes in Turkish patients
26. Hepatitis C virus genotypes in patients with hepatocellular carcinoma
27. Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients
28. Interferon-alpha treatment induces delayed CD4 proliferative responses to the hepatitis C virus nonstructural protein 3 regardless of the outcome of therapy
29. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: Effects of interferon-alpha (IFN-alpha) treatment
30. Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection